Picture of Viatris logo

VTRS Viatris Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapSuper Stock

Momentum

Relative Strength (%)
1m+0.89%
3m-7.95%
6m+0.87%
1yr-21.39%
Volume Change (%)
10d/3m-1.64%
Price vs... (%)
52w High-40.96%
50d MA-5.37%
200d MA-19.14%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)2.75
PEG Ratio (f)0.12
EPS Growth (f)28.56%
Dividend Yield (f)5.99%
Valuation (ttm)IndustryMarket
Price to Book Value0.56
Price to Tang. Bookn/a
Price to Free Cashflow3.68
Price to Sales0.65
EV to EBITDA6.61

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital3.51%
Return on Equity3.71%
Operating Margin8.88%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total Revenue$m11,907.711,433.911,500.511,94617,886.316,515.6716,037.5910.06%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-8.73-29.62-31.53-39.51-92.37+6149.08-2.09n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Viatris EPS forecast chart

Profile Summary

Viatris Inc. is a global healthcare company. The Company has four segments: Developed Markets, Greater China, JANZ and Emerging Markets. Developed Markets segment comprises its operations primarily in North America and Europe. Greater China segment includes its operations in China, Taiwan and Hong Kong. JANZ segment reflects its operations in Japan, Australia and New Zealand. Emerging Markets segment encompasses its presence in approximately 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East, as well as its anti-retroviral franchise. Its portfolio comprises approximately 1,400 approved molecules across a range of key therapeutic areas, including globally recognized iconic and key brands, generics, complex generics, and biosimilars. It operates approximately 40 manufacturing sites worldwide, which produces oral solid doses, injectables, complex dosage forms and active pharmaceutical ingredients.

Directors

Last Annual
December 31st, 2021
Last Interim
June 30th, 2022
Incorporated
February 14th, 2019
Public Since
April 29th, 2020
No. of Shareholders
113,007
No. of Employees
37,000
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
us flag iconNASDAQ Global Select Market
Shares in Issue
1,212,580,940

VTRS Share Price Performance

Upcoming Events for VTRS

Q3 2022 Viatris Inc Earnings Release

Q4 2022 Viatris Inc Earnings Release

Similar to VTRS

Picture of Abcam logo

Abcam

us flag iconNASDAQ Global Select Market

Picture of Amgen logo

Amgen

us flag iconNASDAQ Global Select Market

Picture of Amphastar Pharmaceuticals logo

Amphastar Pharmaceuticals

us flag iconNASDAQ Global Select Market

Picture of Amryt Pharma logo

Amryt Pharma

us flag iconNASDAQ Global Select Market

Picture of Amylyx Pharmaceuticals logo

Amylyx Pharmaceuticals

us flag iconNASDAQ Global Select Market

FAQ

Or unlock with your email

Or unlock with your email